180 related articles for article (PubMed ID: 38517293)
1. Descriptive analysis and prognostic factors in cats with myeloma-related disorders: A multicenter retrospective study of 50 cases.
Lecot L; Desmas-Bazelle I; Benjamin S; De Fornel P; Ponce F; Kornya M; Desquilbet L; Beaudu-Lange C; Ibisch C; Sayag D; Benchekroun G; Béguin J
J Vet Intern Med; 2024; 38(3):1693-1705. PubMed ID: 38517293
[TBL] [Abstract][Full Text] [Related]
2. Clinical Signs, Treatment, and Outcome in Cats with Myeloma-Related Disorder Receiving Systemic Therapy.
Cannon CM; Knudson C; Borgatti A
J Am Anim Hosp Assoc; 2015; 51(4):239-48. PubMed ID: 26083436
[TBL] [Abstract][Full Text] [Related]
3. Myeloma-related disorders in cats commonly present as extramedullary neoplasms in contrast to myeloma in human patients: 24 cases with clinical follow-up.
Mellor PJ; Haugland S; Murphy S; Smith KC; Holloway A; Archer J; Powell RM; Polton GA; Tasker S; McCormick D; Tempest ME; McNeil PE; Scase TJ; Knott CD; Bonfanti U; Villiers EJ; Argyle DJ; Herrtage ME; Day MJ
J Vet Intern Med; 2006; 20(6):1376-83. PubMed ID: 17186853
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.
Webster J; McNaught KA; Morris JS
J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma in 16 cats: a retrospective study.
Patel RT; Caceres A; French AF; McManus PM
Vet Clin Pathol; 2005 Dec; 34(4):341-52. PubMed ID: 16270258
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic, immunohistochemical, and cytologic analysis of feline myeloma-related disorders: further evidence for primary extramedullary development in the cat.
Mellor PJ; Haugland S; Smith KC; Powell RM; Archer J; Scase TJ; Villiers EJ; McNeil PE; Nixon C; Knott C; Fournier D; Murphy S; Polton GA; Belford C; Philbey AW; Argyle DJ; Herrtage ME; Day MJ
Vet Pathol; 2008 Mar; 45(2):159-73. PubMed ID: 18424828
[TBL] [Abstract][Full Text] [Related]
7. Co-infection with Anaplasma platys, Bartonella henselae, Bartonella koehlerae and 'Candidatus Mycoplasma haemominutum' in a cat diagnosed with splenic plasmacytosis and multiple myeloma.
Qurollo BA; Balakrishnan N; Cannon CZ; Maggi RG; Breitschwerdt EB
J Feline Med Surg; 2014 Aug; 16(8):713-20. PubMed ID: 24445821
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma in a cat.
Farrow BR; Penny R
J Am Vet Med Assoc; 1971 Mar; 158(5):606-11. PubMed ID: 5101888
[No Abstract] [Full Text] [Related]
9. Myeloma-related disorder with leukaemic progression in a cat.
Takeuchi Y; Iizuka H; Kanemitsu H; Fujino Y; Nakashima K; Uchida K; Ohno K; Nakayama H; Tsujimoto H
J Feline Med Surg; 2010 Dec; 12(12):982-7. PubMed ID: 21036087
[TBL] [Abstract][Full Text] [Related]
10. Erythrophagocytic multiple myeloma in a cat.
Webb J; Chary P; Northrup N; Almy F
Vet Clin Pathol; 2008 Sep; 37(3):302-7. PubMed ID: 18761523
[TBL] [Abstract][Full Text] [Related]
11. Multiple myelomas in cats.
Hanna F
J Feline Med Surg; 2005 Oct; 7(5):275-87. PubMed ID: 16112593
[TBL] [Abstract][Full Text] [Related]
12. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Martin OA; Price J
J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
[TBL] [Abstract][Full Text] [Related]
13. Multi-drug combination therapy with vincristine-melphalan-cyclophosphamide-prednisolone was more effective than cyclophosphamide-prednisolone in stage III myeloma. The Nagoya Myeloma Cooperative Study Group.
Shimizu K; Kamiya O; Hamajima N; Mizuno H; Kobayashi M; Hirabayashi N; Takeyama H; Kato R; Kawashima K; Nitta M
Jpn J Cancer Res; 1990 Dec; 81(12):1320-7. PubMed ID: 2126002
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic atypical myeloma with extensive cutaneous involvement in a dog.
Fukumoto S; Hanazono K; Kawasaki N; Hori Y; Higuchi S; Sasaki T; Temma K; Uchide T
J Vet Med Sci; 2012 Jan; 74(1):111-5. PubMed ID: 21873808
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma.
Teske E; van Lankveld AJ; Rutteman GR
Vet Comp Oncol; 2014 Mar; 12(1):37-46. PubMed ID: 22489828
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for multiple myeloma in the dog.
Matus RE; Leifer CE; MacEwen EG; Hurvitz AI
J Am Vet Med Assoc; 1986 Jun; 188(11):1288-92. PubMed ID: 3721983
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol].
Steinke B; Busch FW; Stapelfeld S; Ostendorf P; Waller HD
Dtsch Med Wochenschr; 1984 Jun; 109(26):1015-9. PubMed ID: 6547386
[TBL] [Abstract][Full Text] [Related]
19. Alternating combination chemotherapy does not delay development of refractoriness in myeloma.
Osby E; Beksac M; Reizenstein P
Anticancer Res; 1986; 6(5):1145-7. PubMed ID: 3800322
[TBL] [Abstract][Full Text] [Related]
20. Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Maruyama D; Iida S; Ogawa G; Fukuhara N; Seo S; Miyazaki K; Yoshimitsu M; Kuroda J; Tsukamoto N; Tsujimura H; Hangaishi A; Yamauchi T; Utsumi T; Mizuno I; Takamatsu Y; Nagata Y; Minauchi K; Ohtsuka E; Hanamura I; Yoshida S; Yamasaki S; Suehiro Y; Kamiyama Y; Tsukasaki K; Nagai H
Br J Haematol; 2021 Feb; 192(3):531-541. PubMed ID: 32583431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
